Icosavax, Inc. (NASDAQ:ICVX – Get Free Report) was the recipient of a large drop in short interest during the month of January. As of January 31st, there was short interest totalling 321,300 shares, a drop of 35.7% from the January 15th total of 499,700 shares. Based on an average daily volume of 905,900 shares, the […]
Icosavax (NASDAQ:ICVX – Get Free Report) and Freeline Therapeutics (NASDAQ:FRLN – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, dividends and profitability. Analyst Ratings This is a breakdown of recent […]
Icosavax, Inc. (NASDAQ:ICVX – Get Free Report) CEO Adam K. Simpson sold 90,000 shares of the firm’s stock in a transaction on Thursday, December 21st. The stock was sold at an average price of $15.44, for a total transaction of $1,389,600.00. Following the transaction, the chief executive officer now directly owns 260,641 shares of the […]
Icosavax, Inc. (NASDAQ:ICVX – Get Free Report) CFO Thomas Joseph Russo sold 15,183 shares of the company’s stock in a transaction dated Wednesday, December 20th. The shares were sold at an average price of $15.46, for a total transaction of $234,729.18. Following the sale, the chief financial officer now owns 38,037 shares in the company, […]
Icosavax, Inc. (NASDAQ:ICVX – Get Free Report) CFO Thomas Joseph Russo sold 15,183 shares of the company’s stock in a transaction that occurred on Wednesday, December 20th. The shares were sold at an average price of $15.46, for a total value of $234,729.18. Following the transaction, the chief financial officer now directly owns 38,037 shares […]